| - GRCh37:
- Chr2:71894601
- GRCh38:
- Chr2:71667471
| DYSF | E1752K, E1753K, E1766K, E1767K, E1773K, E1774K, E1783K, E1784K, E1787K, E1788K, E1797K, E1798K, E1804K, E1805K | not provided, Qualitative or quantitative defects of dysferlin | Conflicting interpretations of pathogenicity (Mar 13, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:71900503-71913622
| DYSF | | Qualitative or quantitative defects of dysferlin | Pathogenic (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71707993-71709120
| DYSF | | Qualitative or quantitative defects of dysferlin | Pathogenic (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71793585-71797846
| DYSF | | Qualitative or quantitative defects of dysferlin | Pathogenic (Jan 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71693963-71744179
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely pathogenic (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71755408-71755551
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely pathogenic (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71681129-71913622
| DYSF | | Qualitative or quantitative defects of dysferlin | Uncertain significance (Apr 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71838365-71840553
| DYSF | | Qualitative or quantitative defects of dysferlin | Pathogenic (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71730324-71730469
| DYSF | | Qualitative or quantitative defects of dysferlin | Pathogenic (Feb 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71827822-71827982
| DYSF | | Qualitative or quantitative defects of dysferlin | Pathogenic (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71801318-71801511
| DYSF | | Qualitative or quantitative defects of dysferlin | Pathogenic (Sep 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71681119-71694073
| DYSF | | Qualitative or quantitative defects of dysferlin | Pathogenic (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71740885
- GRCh38:
- Chr2:71513755
| DYSF | T166S, T167S, T197S, T198S | Qualitative or quantitative defects of dysferlin | Likely benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71796983
- GRCh38:
- Chr2:71569853
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71743392
- GRCh38:
- Chr2:71516262
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71747987
- GRCh38:
- Chr2:71520857
| DYSF | Y336H, Y337H, Y367H, Y368H | Qualitative or quantitative defects of dysferlin | Uncertain significance (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71740983
- GRCh38:
- Chr2:71513853
| DYSF | G199R, G200R, G230R, G231R | Qualitative or quantitative defects of dysferlin | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71839931-71839932
- GRCh38:
- Chr2:71612801-71612802
| DYSF | G1429V, G1430V, G1443V, G1444V, G1460V, G1461V, G1474V, G1475V | Qualitative or quantitative defects of dysferlin | Uncertain significance (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71838738
- GRCh38:
- Chr2:71611608
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71825761
- GRCh38:
- Chr2:71598631
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71886163
- GRCh38:
- Chr2:71659033
| DYSF | K1584N, K1585N, K1598N, K1599N, K1605N, K1606N, K1615N, K1616N, K1619N, K1620N, K1629N, K1630N, K1636N, K1637N | Qualitative or quantitative defects of dysferlin | Uncertain significance (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71739014
- GRCh38:
- Chr2:71511884
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Apr 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71778859
- GRCh38:
- Chr2:71551729
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71886136
- GRCh38:
- Chr2:71659006
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71839833
- GRCh38:
- Chr2:71612703
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Feb 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71778244
- GRCh38:
- Chr2:71551114
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Mar 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71817405
- GRCh38:
- Chr2:71590275
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71825693
- GRCh38:
- Chr2:71598563
| DYSF | | Qualitative or quantitative defects of dysferlin | Pathogenic (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71780930
- GRCh38:
- Chr2:71553800
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71839760
- GRCh38:
- Chr2:71612630
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Aug 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71797072
- GRCh38:
- Chr2:71569942
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Apr 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71839926
- GRCh38:
- Chr2:71612796
| DYSF | Q1442H, Q1428H, Q1459H, Q1472H, Q1441H, Q1458H, Q1427H, Q1473H | Qualitative or quantitative defects of dysferlin | Uncertain significance (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71906223-71906231
- GRCh38:
- Chr2:71679093-71679101
| DYSF | | Qualitative or quantitative defects of dysferlin | Uncertain significance (Mar 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71838613
- GRCh38:
- Chr2:71611483
| DYSF | R1329G, R1373G, R1374G, R1342G, R1343G, R1359G, R1328G, R1360G | Qualitative or quantitative defects of dysferlin | Pathogenic (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71783115
- GRCh38:
- Chr2:71555985
| DYSF | H694fs, H710fs, H679fs, H693fs, H711fs, H680fs, H724fs, H725fs | Qualitative or quantitative defects of dysferlin | Pathogenic (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71753461
- GRCh38:
- Chr2:71526331
| DYSF | E390*, E420*, E389*, E421* | Qualitative or quantitative defects of dysferlin | Pathogenic (Jun 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71740868-71740869
- GRCh38:
- Chr2:71513738-71513739
| DYSF | E161fs, E192fs, E193fs, E162fs | Qualitative or quantitative defects of dysferlin | Pathogenic (May 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71738950
- GRCh38:
- Chr2:71511820
| DYSF | L120P, L119P | Qualitative or quantitative defects of dysferlin | Pathogenic (Feb 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71730450
- GRCh38:
- Chr2:71503320
| DYSF | | Qualitative or quantitative defects of dysferlin | Pathogenic (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71894659
- GRCh38:
- Chr2:71667529
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71791213
- GRCh38:
- Chr2:71564083
| DYSF | V780D, V812D, V825D, V781D, V811D, V826D, V794D, V795D | Qualitative or quantitative defects of dysferlin, not provided | Uncertain significance (Aug 25, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:71871138
- GRCh38:
- Chr2:71644008
| DYSF | I1486T, I1507T, I1523T, I1524T, I1471T, I1472T, I1492T, I1493T, I1516T, I1517T, I1502T, I1506T, I1485T, I1503T | Qualitative or quantitative defects of dysferlin | Likely benign (Oct 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71906228
- GRCh38:
- Chr2:71679098
| DYSF | K1923E, K1944E, K1954E, K1959E, K1938E, K1955E, K1958E, K1968E, K1976E, K1945E, K1975E, K1924E, K1937E, K1969E | Qualitative or quantitative defects of dysferlin | Uncertain significance (Dec 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71838456
- GRCh38:
- Chr2:71611326
| DYSF | L1330F, L1347F, L1315F, L1316F, L1329F, L1360F, L1346F, L1361F | Qualitative or quantitative defects of dysferlin | Benign (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71908172
- GRCh38:
- Chr2:71681042
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71906211
- GRCh38:
- Chr2:71679081
| DYSF | R1931H, R1939H, R1953H, R1970H, R1952H, R1969H, R1917H, R1938H, R1949H, R1918H, R1932H, R1948H, R1962H, R1963H | Qualitative or quantitative defects of dysferlin | Likely benign (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71829912
- GRCh38:
- Chr2:71602782
| DYSF, LOC122787137 | E1294K, E1295K, E1311K, E1325K, E1312K, E1326K, E1280K, E1281K | Qualitative or quantitative defects of dysferlin | Uncertain significance (Jun 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71681153
- GRCh38:
- Chr2:71454023
| DYSF | A9T | Qualitative or quantitative defects of dysferlin | Uncertain significance (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71796930
- GRCh38:
- Chr2:71569800
| DYSF | | Qualitative or quantitative defects of dysferlin | Uncertain significance (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71797711
- GRCh38:
- Chr2:71570581
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71801515
- GRCh38:
- Chr2:71574385
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71776531
- GRCh38:
- Chr2:71549401
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71829950
- GRCh38:
- Chr2:71602820
| LOC122787137, DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71896743
- GRCh38:
- Chr2:71669613
| DYSF | I1845T, I1846T, I1853T, I1862T, I1852T, I1876T, I1884T, I1831T, I1832T, I1863T, I1866T, I1867T, I1877T, I1883T | Inborn genetic diseases, Qualitative or quantitative defects of dysferlin | Uncertain significance (Dec 21, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:71896890
- GRCh38:
- Chr2:71669760
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71909699
- GRCh38:
- Chr2:71682569
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71871088
- GRCh38:
- Chr2:71643958
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71740853
- GRCh38:
- Chr2:71513723
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Oct 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71896267
- GRCh38:
- Chr2:71669137
| DYSF | N1806Y, N1820Y, N1836Y, N1851Y, N1857Y, N1805Y, N1826Y, N1858Y, N1819Y, N1840Y, N1850Y, N1827Y, N1837Y, N1841Y | Qualitative or quantitative defects of dysferlin | Uncertain significance (Sep 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71840477
- GRCh38:
- Chr2:71613347
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Oct 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71825708
- GRCh38:
- Chr2:71598578
| DYSF | V1180I, V1197I, V1196I, V1165I, V1166I, V1179I, V1211I, V1210I | Qualitative or quantitative defects of dysferlin, not provided | Uncertain significance (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:71753404
- GRCh38:
- Chr2:71526274
| DYSF | R370W, R402W, R371W, R401W | Qualitative or quantitative defects of dysferlin | Uncertain significance (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71838720
- GRCh38:
- Chr2:71611590
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jul 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71797756-71797757
- GRCh38:
- Chr2:71570626-71570627
| DYSF | E1007fs, E1008fs, E1038fs, E1039fs, E1052fs, E1022fs, E1021fs, E1053fs | Qualitative or quantitative defects of dysferlin | Pathogenic (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71783212
- GRCh38:
- Chr2:71556082
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Oct 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71838442
- GRCh38:
- Chr2:71611312
| DYSF | N1311T, N1324T, N1356T, N1310T, N1325T, N1342T, N1355T, N1341T | Qualitative or quantitative defects of dysferlin | Uncertain significance (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71780951
- GRCh38:
- Chr2:71553821
| DYSF | Y635H, Y636H, Y649H, Y667H, Y681H, Y650H, Y666H, Y680H | Qualitative or quantitative defects of dysferlin | Likely benign (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71744177
- GRCh38:
- Chr2:71517047
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jan 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71838488
- GRCh38:
- Chr2:71611358
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71762384
- GRCh38:
- Chr2:71535254
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (May 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71755530
- GRCh38:
- Chr2:71528400
| DYSF | M429T, M459T, M460T, M428T | Qualitative or quantitative defects of dysferlin | Uncertain significance (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71766337
- GRCh38:
- Chr2:71539207
| DYSF | S483W, S484W, S515W, S514W | Qualitative or quantitative defects of dysferlin | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71780166
- GRCh38:
- Chr2:71553036
| DYSF | S610F, S611F, S580F, S594F, S625F, S593F, S624F, S579F | Qualitative or quantitative defects of dysferlin | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71796936-71796937
- GRCh38:
- Chr2:71569806-71569807
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (May 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71744183
- GRCh38:
- Chr2:71517053
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71883301
- GRCh38:
- Chr2:71656171
| DYSF | T1514A, T1539A, T1507A, T1524A, T1538A, T1545A, T1508A, T1546A, T1493A, T1494A, T1515A, T1525A, T1528A, T1529A | Qualitative or quantitative defects of dysferlin | Uncertain significance (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71817336
- GRCh38:
- Chr2:71590206
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71778775
- GRCh38:
- Chr2:71551645
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71747996
- GRCh38:
- Chr2:71520866
| DYSF | T340A, T370A, T339A, T371A | Qualitative or quantitative defects of dysferlin | Uncertain significance (Jan 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71913570
- GRCh38:
- Chr2:71686440
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71797482
- GRCh38:
- Chr2:71570352
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jun 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71896725
- GRCh38:
- Chr2:71669595
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71708989
- GRCh38:
- Chr2:71481859
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71801357
- GRCh38:
- Chr2:71574227
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71797751
- GRCh38:
- Chr2:71570621
| DYSF | I1005M, I1004M, I1019M, I1035M, I1050M, I1018M, I1049M, I1036M | Qualitative or quantitative defects of dysferlin | Uncertain significance (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71740879
- GRCh38:
- Chr2:71513749
| DYSF | G165E, G195E, G196E, G164E | Qualitative or quantitative defects of dysferlin | Uncertain significance (Oct 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71871186
- GRCh38:
- Chr2:71644056
| DYSF | T1502I, T1539I, T1508I, T1519I, T1523I, T1533I, T1540I, T1488I, T1501I, T1509I, T1522I, T1532I, T1487I, T1518I | Qualitative or quantitative defects of dysferlin | Likely benign (May 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71778826
- GRCh38:
- Chr2:71551696
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71762226
- GRCh38:
- Chr2:71535096
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71730334
- GRCh38:
- Chr2:71503204
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71886040
- GRCh38:
- Chr2:71658910
| DYSF | D1543E, D1564E, D1589E, D1544E, D1565E, D1575E, D1578E, D1595E, D1596E, D1557E, D1558E, D1574E, D1588E, D1579E | Qualitative or quantitative defects of dysferlin | Uncertain significance (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71840475
- GRCh38:
- Chr2:71613345
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Aug 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71871093
- GRCh38:
- Chr2:71643963
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely pathogenic (Jul 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71730448
- GRCh38:
- Chr2:71503318
| DYSF | G115V, G114V | Qualitative or quantitative defects of dysferlin | Uncertain significance (Mar 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71891389
- GRCh38:
- Chr2:71664259
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71788902
- GRCh38:
- Chr2:71561772
| DYSF | H714R, H729R, H760R, H715R, H745R, H728R, H746R, H759R | Qualitative or quantitative defects of dysferlin | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71709090
- GRCh38:
- Chr2:71481960
| DYSF | G76R, G77R | Qualitative or quantitative defects of dysferlin | Uncertain significance (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71762439
- GRCh38:
- Chr2:71535309
| DYSF | W467fs, W498fs, W466fs, W497fs | Qualitative or quantitative defects of dysferlin | Pathogenic (Jan 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71883368
- GRCh38:
- Chr2:71656238
| DYSF | R1529Q, R1551Q, R1560Q, R1516Q, R1546Q, R1536Q, R1537Q, R1547Q, R1550Q, R1568Q, R1515Q, R1530Q, R1561Q, R1567Q | Qualitative or quantitative defects of dysferlin | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71796946
- GRCh38:
- Chr2:71569816
| DYSF | | Qualitative or quantitative defects of dysferlin | Likely benign (Jun 2, 2022) | criteria provided, single submitter |